首页> 外文期刊>Toxicology in vitro: an international journal published in association with BIBRA >Di-n-butyl phthalate modifies PMA-induced macrophage differentiation of THP-1 monocytes via PPAR gamma
【24h】

Di-n-butyl phthalate modifies PMA-induced macrophage differentiation of THP-1 monocytes via PPAR gamma

机译:邻苯二甲酸酯通过PPARγ改变PMA诱导的PMA-1单核细胞的巨噬细胞分化

获取原文
获取原文并翻译 | 示例
           

摘要

The present study examined the effects of di-n-butyl phthalate (DBP) on phorbol myristate acetate (PMA)-induced macrophage differentiation of THP-1 monocytes, determined by morphological classification and flow cytometry. Focusing on the expression of the surface marker CD36, the potential role of peroxisome proliferator-activated receptor gamma (PPAR gamma) was examined using various PPAR gamma agonists and antagonists. As the PPAR gamma ligand-binding domain contains multiple ligand-binding sites (LBS), agonist and antagonists targeting the different sites were used. DBP accelerated PMA-induced morphological changes and increased expression of CD36, although to a lesser degree than the PPAR gamma agonists rosiglitazone and 15-deoxy-Delta 12,14-prostaglandin J(2) (15d-PGJ(2)). A proteomics screening revealed that DBP enhanced the expression of PPAR gamma-regulated proteins. During combined exposures, DBP partly attenuated the effect of rosiglitazone, an agonist binding reversibly to PPAR gamma's canonical LBS. In contrast, DBP increased expression of CD36 in combination with 15d-PGJ(2) which binds irreversibly to the canonical LBS. Thus, DBP appears to interact with both the canonical and alternative LBS. Accordingly, the antagonist GW9662, which binds to the canonical LBS, only partly reduced the DBP-induced CD36 expression, while the dual-site antagonist SR16832 completely blocked the effects of DBP. Overall, the results show that DBP modifies PMA-induced differentiation of THP-1 cells through interaction with PPAR gamma.
机译:本研究检测了邻苯二甲酸二叔丁酯(DBP)对Phorbol Mertirtate醋酸酯(PMA)的影响 - 诱导THP-1单核细胞的巨噬细胞分化,通过形态学分类和流式细胞术确定。专注于表面标记CD36的表达,使用各种PPARγ激动剂和拮抗剂检查过氧化物体增殖物激活的受体γ(PPARγ)的潜在作用。由于PPARγ配体结合结构域含有多个配体结合位点(LBS),使用靶向不同位点的激动剂和拮抗剂。 DBP加速PMA诱导的形态变化和CD36表达增加,尽管比PPARγ激动剂Rosiglitazone和15-脱氧 - δ12,14-前列腺素J(2)(15d-pgj(2))的程度较小。蛋白质组学筛选表明,DBP增强了PPARγ调节蛋白的表达。在组合曝光期间,DBP部分抑制了Rosiglitazone的作用,其可逆地与PPARγ的规范液晶液相同的激动剂结合。相反,DBP与15D-PGJ(2)组合的CD36的表达增加,其不可逆地结合到规范LBS。因此,DBP似乎与规范和替代LBS相互作用。因此,结合规范LBS的拮抗剂GW9662仅部分地减少了DBP诱导的CD36表达,而双位点拮抗剂SR16832完全阻断了DBP的效果。总体而言,结果表明,DBP通过与PPARγ的相互作用改变PMA诱导的THP-1细胞的分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号